POLE and colorectal cancer: Of note, Espinosa et al. [90], in evaluating the survival rate, observed that patients affected by EDCs with POLE domain mutations had a better prognosis than patients affected by advanced colorectal cancer with POLE domain mutations who had a statistically significant increase in mortality despite adjuvant therapy treatment [90].